|
Location: (b)(6).Product involved in the event: arrive guiding sheath 10fr sheath model/ref 990061-055 (lot:c1- 12713) and a medtronic brockenbrough curved transeptal needle model/ref ep003994s( lot: 211439989).Event description: prior to the procedure, physician performed a demo run with the sheath and medtronic curved transseptal needle.After insertion of the needle into the dilator, he flushed the dilator and small fragment from the inner lumen of the dilator were seen flushed out.The physician then proceeded to use another sheath with a st.Jude medical brk needle, performed another demo run and no fragments were flushed out.The physician then proceeded to perform the procedure with the arrive sheath and the device worked fine.
|
|
The device was used in a cryo pvi procedure.The returned dilator was reviewed and was shown to meet all design specifications.When bisected, the returned dilator showed evidence of slight skiving on the shaft.Testing has shown that the transseptal needle, in combination with the dilator is potentially susceptible to skiving.No patient injuries were reported with this complaint.Additional investigation testing has shown that the transseptal needle, in combination with the dilator is potentially susceptible to skiving.This testing demonstrates that the risk of skiving is possible with a range of transseptal needle types.Additional testing was conducted to assess possible design changes for the arrive dilator along with testing competitor dilators used for transseptal procedures.All proposed product designs and competitor dilators demonstrated the susceptibility to skiving.This testing demonstrates that no changes could be made to the arrive dilator to further mitigate the risk of skiving.Per the arrive sheath clinical evidence report (cer), the clinical evaluation of the sheath and dilator demonstrate the clinical safety and performance of the device.The outputs of the risk management process, the device-body interaction, and clinical performance of the device demonstrate that the benefit to the patient is greater than any risk identified.The reason for return was confirmed, however, no manufacturing defects were found.Based upon the investigation, a capa has been opened to address this risk.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this device for complaint trends and risk.Per the qa adelante breezeway dilator in-process and final inspection procedure, a blunt ts inspection mandrel is used for insertion into the dilator shaft to check for patency on 100 percent of the dilators.The arrive sheath instructions for use (ifu) instructs when "preparing and managing the transseptal sheath, if a transseptal needle is used, it is recommended to use together with a stylet in order to prevent skiving of the inner lumen of the dilator.".
|